Scarica l'app Stockscreener
0.00
100.00%
-7.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACCD Giù?
Forum
Previsione
Precedente Chiudi:
$7.02
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$562.77M
Reddito:
$414.29M
Utile/perdita netta:
$-99.81M
Rapporto P/E:
0.00
EPS:
-1.3348
Flusso di cassa netto:
$-28.65M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$8.24
Accolade Inc Stock (ACCD) Company Profile
Nome
Accolade Inc
Settore
Industria
Telefono
610-834-2989
Indirizzo
660 W. GERMANTOWN PIKE SUITE 500, PLYMOUTH MEETING
Confronta ACCD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACCD
Accolade Inc
|
0.00 | 562.77M | 414.29M | -99.81M | -28.65M | -1.3348 |
|
VEEV
Veeva Systems Inc
|
231.64 | 35.11B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.75 | 9.83B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
54.29 | 7.48B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
86.42 | 7.22B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.03 | 6.10B | 906.14M | -52.62M | 89.62M | -0.3621 |
Accolade Inc Stock (ACCD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Reiterato | Needham | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-17 | Ripresa | DA Davidson | Neutral |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-05-24 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-23 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-02-09 | Downgrade | Jefferies | Buy → Hold |
| 2023-02-02 | Iniziato | Raymond James | Outperform |
| 2022-09-08 | Ripresa | Piper Sandler | Overweight |
| 2022-09-07 | Iniziato | Truist | Buy |
| 2022-08-12 | Iniziato | DA Davidson | Buy |
| 2022-05-02 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-04-29 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-29 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-04-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-29 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Underweight |
| 2022-04-07 | Iniziato | Guggenheim | Neutral |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-09-30 | Iniziato | Berenberg | Buy |
| 2021-09-17 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-05-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-04-15 | Iniziato | Needham | Buy |
| 2021-03-11 | Ripresa | Goldman | Buy |
| 2021-01-15 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-12-08 | Iniziato | Canaccord Genuity | Buy |
| 2020-09-22 | Iniziato | DA Davidson | Buy |
| 2020-07-27 | Iniziato | BofA Securities | Buy |
| 2020-07-27 | Iniziato | Credit Suisse | Neutral |
| 2020-07-27 | Iniziato | Goldman | Buy |
| 2020-07-27 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-27 | Iniziato | Piper Sandler | Overweight |
| 2020-07-27 | Iniziato | Robert W. Baird | Outperform |
| 2020-07-27 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Accolade Inc Borsa (ACCD) Ultime notizie
Press Release Distribution & PR Platform - ACCESS Newswire
Adventus Singapore Pte. Ltd. bags accolade at SBR National Business Awards 2025 - Singapore Business Review
Accolade president Robert Cavanaugh sells shares worth $3,857 - MSN
Digital health startup Transcarent takes Accolade private in $621 million deal - MSN
MedEthix Inc earns two accolades at Healthcare Asia Pharma Awards 2025 - Healthcare Asia Magazine
Transcarent finalizes merger with Accolade - MobiHealthNews
Telehealth startup completes $621 million acquisition of Seattle's Accolade - The Business Journals
Accolade completes merger with Transcarent, shifts control By Investing.com - Investing.com Canada
Accolade completes merger with Transcarent, shifts control - Investing.com
Transcarent Completes Merger With Accolade - Business Wire
AcCOLADE president Robert Cavanaugh sells $3,845 in stock By Investing.com - Investing.com Canada
Accolade EVP general counsel sells $2,642 in stock - Investing.com Australia
Accolade EVP general counsel sells $2,642 in stock By Investing.com - Investing.com South Africa
AcCOLADE president Robert Cavanaugh sells $3,845 in stock - Investing.com
Accolade’s CFO Stephen Barnes sells shares worth $3,013 By Investing.com - Investing.com South Africa
Accolade’s CFO Stephen Barnes sells shares worth $3,013 - Investing.com
Accolade, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Accolade (ACCD) - ACCESS Newswire
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Accolade, Inc. (ACCD) - ACCESS Newswire
Is Accolade Inc. (NASDAQ:ACCD) the Best Performing Stock So Far In 2025? - MSN
Accolade shareholders approve merger with Transcarent By Investing.com - Investing.com India
Accolade Stockholders Approve Merger with Transcarent - TipRanks
Accolade Shareholders Greenlight Merger With Transcarent - MarketScreener
Accolade shareholders approve merger with Transcarent - Investing.com
Accolade Stockholders Approve Merger Between Accolade and Transcarent - GlobeNewswire
GLAZER CAPITAL, LLC Acquires Significant Stake in Accolade Inc - GuruFocus
Accolade president Robert Cavanaugh sells $1,264 in stock By Investing.com - Investing.com Australia
Accolade CFO Stephen H. Barnes sells $991 worth of stock By Investing.com - Investing.com Australia
Accolade CEO Rajeev Singh sells $2,018 in stock By Investing.com - Investing.com Australia
Accolade president Robert Cavanaugh sells $1,264 in stock - Investing.com India
Accolade CEO Rajeev Singh sells $2,018 in stock - Investing.com India
Accolade CFO Stephen H. Barnes sells $991 worth of stock - Investing.com
STOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of ACCD, SKGR, AVAV, WMPN to Act Now - The Malaysian Reserve
Do Options Traders Know Something About Accolade (ACCD) Stock We Don't? - Barchart
AcCOLADE CFO Stephen Barnes sells $1,769 in stock By Investing.com - Investing.com Canada
Accolade Inc Stock: $621M Transcarent Buyout Sends Shares Soaring - sharewise
Accolade president Robert Cavanaugh sells shares worth $1,734 By Investing.com - Investing.com Canada
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of ACCD, SKGR, AVAV, WMPN to Act Now - GlobeNewswire Inc.
Accolade Inc Azioni (ACCD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):